diphenylcyclopropenone has been researched along with Hypermelanosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Durdu, M; Özcan, D; Seçkin, D | 1 |
| Holmes, S; Lamb, RC; Young, D | 1 |
| Inui, S; Itami, S; Nakajima, T; Toda, N | 1 |
| Hori, Y; Urabe, K | 1 |
| Pericin, M; Trüeb, RM | 1 |
1 review(s) available for diphenylcyclopropenone and Hypermelanosis
| Article | Year |
|---|---|
Dyschromatosis.
Topics: Age Factors; Amyloidosis; Cloning, Molecular; Cyclopropanes; Diagnosis, Differential; Extremities; Foot Dermatoses; Hand Dermatoses; Humans; Hydroquinones; Hyperpigmentation; Hypopigmentation; Infant, Newborn; Japan; Pigmentation Disorders; Skin Diseases; Xeroderma Pigmentosum | 1997 |
1 trial(s) available for diphenylcyclopropenone and Hypermelanosis
| Article | Year |
|---|---|
Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Arthralgia; Blister; Chi-Square Distribution; Cyclopropanes; Eczema; Erythema Multiforme; Female; Fever; Hair; Humans; Hyperpigmentation; Immunoglobulin G; Immunotherapy; Logistic Models; Male; Middle Aged; Retrospective Studies; Serum Sickness; Time Factors; Treatment Outcome | 1998 |
3 other study(ies) available for diphenylcyclopropenone and Hypermelanosis
| Article | Year |
|---|---|
Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Alopecia Areata; Anthralin; Apoptosis; CD4-CD8 Ratio; Child; Cyclopropanes; Cytokines; Drug Eruptions; Drug Evaluation; Drug Therapy, Combination; Female; Folliculitis; Follow-Up Studies; Humans; Hyperpigmentation; Immunotherapy; Male; Middle Aged; Pruritus; Retrospective Studies; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome; Young Adult | 2015 |
Retrospective review of diphencyprone in the treatment of alopecia areata.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Aged; Alopecia Areata; Cyclopropanes; Eczema; Female; Hair; Headache; Humans; Hyperpigmentation; Immunotherapy; Lymphadenopathy; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2016 |
Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Cyclopropanes; Dermatitis, Contact; Dermatologic Agents; Female; Humans; Hyperpigmentation; Immunotherapy; Male; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2010 |